Exxon Mobil XOM

Reference table

1. The entity changed on 1 July 2026 — what that does and does not mean

This must be dealt with first, because the filings in this file are split across two legal entities and a careless reading would attribute the wrong company's annual report.

What happened, from Note 1 of the 10-Q filed 2026-08-03, verbatim in substance: on 1 July 2026, Exxon Mobil Corporation ("EMC"), a New Jersey corporation, completed a redomiciliation reorganization under which ExxonMobil Holdings Corporation ("EMHC"), a Texas corporation, became the publicly traded parent of the ExxonMobil consolidated group. Each outstanding share of EMC common stock was automatically exchanged for one share of EMHC common stock, par value $0.001, and former EMC shareholders held the same number and percentage ownership interests immediately afterwards. EMHC replaced EMC on the New York Stock Exchange under the ticker "XOM" and became the successor registrant under Rule 12g-3(a).

What changed: shareholder rights are now governed by the Texas Business Organizations Code and EMHC's organisational documents, where previously they were governed by the New Jersey Business Corporation Act. That is a real governance change — different statutory law on fiduciary duties, appraisal, derivative suits and shareholder proposals — and it is the only substantive consequence.

What did not change, quoting the filing: the Redomiciliation Merger "did not change the Corporation's consolidated business, operations, assets, liabilities, or financial reporting basis."

How that maps onto the filings in this file, stated accurately:

A gap that must be stated: both 8-K extracts contain only the cover page. The Item narrative and all exhibits were lost in extraction. The 2026-07-31 8-K is the Q2'26 earnings release, and its content is not available in this file. The Q2 figures used in this dive therefore come from the 10-Q itself, which is the stronger source anyway. Separately, per the data contract, earnings-call transcripts are not available on this data plan, so no management Q&A informs this dive.

The vendor payload has already migrated: profile.cik reads 0002115436 — the successor. The company name still reads "Exxon Mobil Corporation." Neither is wrong; the successor uses the ExxonMobil name.

2. What actually happened in the second quarter — the single most important section

Q2'26 earnings were $14.5 billion against $7.1 billion a year earlier. First-half 2026 earnings were $18.7 billion against $14.8 billion. Those are the filing's own numbers, and they reconcile exactly to the vendor's quarterly net income of $4.183 billion (Q1'26) plus $14.525 billion (Q2'26) equals $18.708 billion.

The MD&A gives a full earnings bridge by segment. This is the disclosure that decides the verdict, so here it is in full for the second quarter:

Corporate and Financing expense was $954 million in the quarter, $195 million higher than a year earlier on lower interest income and unfavourable tax.

Four things fall out of this table, and every one of them matters.

First, the quarter was overwhelmingly a PRICE event, not a volume event. Price and margin contributed roughly $9,080 million across the four segments. Advantaged volume growth — the part that reflects capital Exxon has deployed and projects it has built — contributed $1,290 million. The ratio is roughly seven to one. Exxon did not out-execute its way to $14.5 billion; it sold into a much better market.

Second, the Middle East disruption is a two-sided event and the filing is unusually clear about it. Every segment except Chemical carries an explicit "Middle East Volume" line reducing earnings — $1,060 million in Upstream, $310 million in Energy Products, $110 million in Specialty, roughly $1.48 billion in total for the quarter. So the same disruption that lifted realisations also stopped barrels moving. That symmetry is important for the forward view: if the disruption resolves, Exxon gets its volumes back but loses the price. The net is genuinely uncertain and should not be assumed favourable.

Third, $2,560 million of Energy Products earnings is a timing artifact that reverses. The filing's own definition of Estimated Timing Effects: impacts "primarily related to unsettled derivatives which are required to be marked to current period-end prices (mark-to-market), where the associated physical shipments are not reflected in earnings until the physical transaction is complete… Impacts are expected to unwind in subsequent periods." Netting Upstream's −$180 million, the quarter carried +$2,380 million of net favourable timing — roughly 16 percent of reported earnings — that management says will come back out. Note that for the first half as a whole the sign flips: Energy Products timing effects were −$770 million for six months (on rising crude prices) against Upstream's −$870 million, so the annual picture is far less flattering than the quarter.

Fourth, identified items were a $2.475 billion drag in the quarter, chiefly impairments and financial reserves. The 10-Q's Note 7 ties part of that to the Louisiana coastal-erosion settlement effective 2026-07-31, which the filing calls "not material to the Corporation, with estimated earnings impacts included in the second quarter financial reserve updates and third quarter earnings impacts expected to be immaterial."

A reconciliation we cannot complete, stated honestly. The vendor's earn_cal reports a Q2'26 "actual" earnings per share of $3.52 against GAAP diluted earnings per share of $3.48 — a difference of roughly $170 million. But the filing discloses $2,475 million of identified items in the quarter. If the street's $3.52 is an earnings-excluding-identified-items figure, it should be roughly $0.60 a share higher than GAAP, not $0.04. We cannot reconcile the vendor's adjusted figure to the filing's identified items, and we do not force it. This dive uses the filing's GAAP figures and the filing's own driver bridge, and treats the vendor's adjusted earnings-per-share series as unverified.

3. The forty-percent return that contains no earnings growth

This is the arithmetic that produces a Hold rather than a Buy.

Now the price. The stock returned +40.4 percent over twelve months, which implies a price roughly twelve months ago of $109.65. Using FY2024 diluted earnings per share of $7.84 as the trailing figure then, and trailing earnings per share of $7.85 now:

> Twelve months ago: ~$109.65 ÷ $7.84 ≈ 14.0x trailing.

> Today: $153.97 ÷ $7.85 = 19.6x trailing.

Trailing earnings per share moved by one cent. The multiple moved by 5.6 turns. The entire twelve-month return — and the sixteen-point outperformance against the S&P — is re-rating. (Labelled as ours and as an approximation: the trailing figure twelve months ago is proxied by the FY2024 annual result because the file does not contain 2024 quarterly statements. The direction and magnitude are not sensitive to that approximation.)

Why this matters more than it would elsewhere. A re-rating is not automatically unjustified — if the market has decided oil deserves a higher multiple, that view can persist for years. But it changes what you are underwriting. A buyer at $109.65 was underwriting cheap assets; a buyer at $153.97 is underwriting that the crowd's new opinion of the multiple is durable AND that the price environment that produced the second quarter persists. Those are two bets, not one.

The knowledge base flagged this exact trap two years before it mattered. A 2024-01-04 claim, neutral, conviction 70: "A low PE on a capital-intensive commodity business like Exxon is misleading — maintenance capex means it's not as cheap as the multiple suggests." The corollary now applies in reverse: a 19.6x multiple on a capital-intensive commodity business at a cyclical high is more expensive than it looks, because the earnings in the denominator are peak earnings.

4. Balance sheet — and, unusually, a vendor figure we can confirm

From the 10-Q filed 2026-08-03, at 30 June 2026:

• Total debt $42.4 billion (down from $43.5 billion at year-end 2025), defined by the company as notes and loans payable plus long-term debt
• Cash and cash equivalents $10.6 billion, excluding restricted cash
• Net debt $31.8 billion
• Total equity $266.1 billion
• Debt to total capital 13.7 percent (14.0 percent at year-end 2025) · net debt to capital 10.7 percent, down 0.3 points
• Undrawn committed credit lines: $7.4 billion short-term, $0.3 billion long-term
• Commercial paper is used for short-term liquidity and sits in "Notes and loans payable"
• Interest coverage 59.6x · debt to equity 0.163 · financial leverage 1.79x

The vendor's enterprise value is CORRECT on this name, and we say so. km_ttm.enterpriseValueTTM reports $669.903 billion against a market capitalisation of $638.123 billion — an implied net debt of $31.780 billion, which matches the filing's $31.8 billion. cashPerShareTTM of $2.537 across ~4,144M shares gives $10.51 billion of cash, matching the filing's $10.6 billion. Short-term investments are genuinely zero for this issuer, so the usual net-cash-reported-as-net-debt failure does not arise. Honesty runs both ways: this is a case where the vendor's enterprise value survives scrutiny and the EV-based multiples are usable.

One historical inconsistency in the vendor's balance sheet, resolved in the vendor's favour for FY2025. capitalLeaseObligations reads $3.838 billion (FY2023), $3.951 billion (FY2024) and $0 (FY2025). In FY2023 and FY2024 the vendor's totalDebt includes those leases; in FY2025 totalDebt of $43.537 billion is exactly short-term debt ($9.296 billion) plus long-term debt ($34.241 billion), excluding them. The filing's own definition of total debt is "the sum of notes and loans payable and long-term debt" — which excludes finance leases — and the filing's year-end 2025 figure of $43.5 billion matches the vendor's FY2025 number. So the FY2025 presentation is right and the FY2023/FY2024 figures are inflated by roughly $3.9 billion relative to the company's own definition. We use the FY2025 and Q2'26 basis and do not compare debt across those years.

5. Cash flow — and the 96 percent

Operating cash flow is falling while capital spending rises. From FY2022 to FY2025, operating cash flow fell 32 percent while capital expenditure rose 54 percent, so free cash flow fell 60 percent, from $58.4 billion to $23.6 billion — even as the buyback and dividend rose from $30.1 billion to $37.5 billion combined. In FY2025, shareholder returns of $37.504 billion exceeded free cash flow of $23.612 billion by $13.9 billion.

The first half of 2026 looks better because the quarter was exceptional: cash flow from operations and asset sales was $24.0 billion in Q2 alone, up $12.3 billion year on year. For the half, $32.3 billion of operating cash flow less $13.0 billion of property additions gives $19.3 billion of free cash flow against $18.6 billion distributed — 96 percent coverage. That is coverage, but it is not comfortable coverage, and it was achieved in the best quarter the company has had in years.

2026 capital spending is guided to $27-29 billion, with $13.0 billion already spent. This is the constraint the whole shareholder-return story runs into if realisations normalise, and it is why the medium-horizon stance is neutral rather than tailwind.

Two supporting details from the filing worth recording: first-half depreciation and depletion was $15.5 billion, up $3.7 billion year on year — which is why "higher depreciation" appears as an earnings drag in three of four segment bridges, and it is a permanent, growing charge as Guyana capital enters service. And divestment proceeds were only $0.6 billion in the first half against $3.2 billion in all of 2025, with after-tax earnings of roughly $0.1 billion against $1.1 billion — so the disposal programme is no longer a meaningful earnings contributor.

6. Valuation — priced in or room?

At $153.97 (market cap $638.12B, ~4.144B shares, net debt $31.8B, enterprise value $669.9B):

Consensus models an earnings plateau, then a decline. $11.07 in FY2026, $10.55 in FY2027, $10.60 in FY2028 — with revenue falling from $377.6 billion to $361.4 billion. Coverage is genuinely deep on FY2027 (14 analysts on EPS, 10 on revenue) and thinner on FY2026 (8) and FY2028 (7). The FY2029 and FY2030 rows carry only 2 and 5 analysts on EPS and no conclusion here rests on them.

The FY2026 consensus is internally coherent with the actual quarterly path, which is a point in its favour: Q1'26 GAAP $1.00, Q2'26 GAAP $3.48, Q3'26E $3.53 (from earn_cal), implying a Q4 of roughly $3.06 to reach $11.07. So the street is explicitly assuming the second-quarter run-rate persists for two more quarters. That is the load-bearing assumption in the whole valuation.

Peer context, with a caveat. The vendor peer set is genuinely relevant — Chevron ($379.2B), Shell ($250.5B), TotalEnergies ($189.7B), Petrobras ($120.6B), Equinor ($93.6B), Suncor ($76.2B), Imperial Oil ($62.4B, in which Exxon holds a 69.6 percent interest per the 10-K), Cenovus, Ecopetrol, YPF. But BP's market capitalisation is reported as $18.55 billion against a share price of $42.44, which is impossible for BP and is rejected as corrupt (Section 8). No peer multiples are supplied in the file, so no peer-multiple comparison is drawn — only the observation that Exxon at $638.1 billion is 1.68 times Chevron and 2.55 times Shell, and that the market has consistently paid a premium for the Guyana-and-Permian position.

The vendor's own scoring model rates Exxon B+ with an overall score of 3, with its two weakest sub-scores being price-to-earnings (2) and price-to-book (2) — the vendor's model agrees the valuation is the problem.

6a. What today's price assumes (the inversion)

At $153.97 — 19.6x trailing, 14.6x FY2027 consensus, 2.48x book — the price embeds roughly the following falsifiable claims:

• That the second-quarter earnings run-rate is the new baseline, not a peak. (Consensus-derived: FY2026E EPS of $11.07 requires roughly $3.30 a quarter in the second half, against a Q2'26 GAAP $3.48 and a Q1'26 GAAP $1.00. The FY2025 actual was $6.70.) This is the most fragile assumption in the price and it is fragile in a specific, documented way: the filing discloses $2,560 million of Energy Products timing effects "expected to unwind in subsequent periods," and a Q2 effective tax rate of 24 percent that was 10 percentage points below the prior year purely on jurisdictional mix.
• That crude realisations and refining margins stay near current levels through 2028. (Consensus-derived: FY2027E and FY2028E EPS of $10.55 and $10.60 sit only 5 percent below FY2026E despite consensus revenue falling $16 billion.) Price and margin contributed roughly $9,080 million of the Q2 improvement against $1,290 million from volume growth — the price assumption is doing seven times the work of the volume assumption.
• That the multiple does not de-rate back toward its own recent history. (Ours: 14.0x trailing twelve months ago against 19.6x today, using FY2024 EPS as the trailing proxy.) At a constant $10.55 of FY2027 earnings, a return to 14x is $148; a move to 13x is $137.
• That shareholder returns of roughly $37 billion a year are sustainable. (Filing-derived: first-half distributions of $18.6 billion against $19.3 billion of free cash flow — 96 percent coverage — in the best quarter in years, with 2026 capex guided to $27-29 billion.) At the FY2025 free cash flow of $23.6 billion, the current return pace is 159 percent of free cash flow.
• That the Middle East disruption resolves benignly — Exxon recovers roughly $1.5 billion a quarter of lost volume earnings without giving back the $9 billion of price and margin benefit. (Ours, derived from the filing's own two-sided bridge.) There is no reason to expect that combination, and the price appears to assume it.

6b. The return bridge (why the multiple moves)

Expected return over 12-24 months decomposes as: earnings growth (roughly ZERO on consensus — $11.07 falling to $10.55 then $10.60) + multiple drift + shareholder yield (~5.8 percent, of which 2.65 percent is the dividend).

With consensus earnings flat to slightly down, essentially all of the expected total return above the 5.8 percent shareholder yield has to come from the multiple. That is the opposite configuration to the one we want: the thesis needs multiple expansion, from an already-expanded multiple, on peak-cycle earnings.

Our base case therefore assumes a modest multiple HOLD, not expansion. The $157 base is 14.9x FY2027 consensus earnings per share of $10.55 — slightly above today's 14.6x, essentially flat. It does not assume a de-rating and it does not assume a re-rating. On that basis the twelve-month expected return is roughly 2 percent of price appreciation plus 5.8 percent of shareholder yield — call it 8 percent, which is a fair but unexceptional outcome for a low-beta commodity major and is exactly why this is a Hold rather than a Buy or an Avoid.

The bear case is where the multiple does the damage. $118 is 11.2x FY2027 consensus, which is not an unusual multiple for an integrated major and would still leave the stock above its 52-week low of $105.83. The single most important thing to understand about the return bridge here is that the multiple, having expanded 5.6 turns in twelve months on no earnings growth, can contract 3.4 turns just as mechanically. That asymmetry — 2 percent of upside to base against 23 percent of downside to bear — is the verdict.

The bull case at $196 (18.6x FY2027E) genuinely requires the disruption-era earnings to prove structural and the market to keep paying a high-teens multiple. That is possible, and the Guyana ramp gives it a real foundation, but it is the fragile leg and it is not needed for the base case.

6c. Variant perception (where we differ, what would surprise)

• We differ from consensus on the durability of the second quarter, and the company's own filing is our evidence. The street's FY2026 estimate of $11.07 requires the Q2 run-rate to hold for two more quarters. The 10-Q discloses $2,560 million of Energy Products timing effects "expected to unwind," a Q2 effective tax rate 10 points below the prior year on jurisdictional mix, and roughly $1.5 billion a quarter of Middle East volume losses that reverse only if the price benefit also reverses. We think a meaningful portion of Q2 is non-repeating and the street has extrapolated it. Watchable number: Q3'26 earnings on 2026-10-30 against a $3.53 consensus — specifically whether Energy Products shows a large negative timing effect.
• We differ on what the twelve-month return means. The market appears to read +40 percent as confirmation of the thesis. On our arithmetic it is confirmation of nothing except that the crowd changed its mind about the multiple: trailing earnings per share moved from $7.84 to $7.85. Watchable number: trailing earnings per share after the Q3 and Q4 prints — if it does not move materially above $9, the re-rating remains unsupported by earnings.
• We differ from ourselves, six weeks ago, and we say so. The knowledge base's most prolific voice on this name — 8 of 29 claims, including a conviction-92 "pounding the table" call in July 2025 and a conviction-75 "electron giants for the AI age" re-rating thesis — explicitly recanted on 2026-06-21: "The oil mega-spike thesis is refuted… Admits his long Exxon/Chevron has only cost money." A high-conviction bull publicly marking his own thesis to market is the highest-information event that can occur in a conviction lane, and it moves our net conviction from positive-high to positive-moderate. Section 7 handles this in full.
• We do NOT differ on the quality of the asset base, and this is important. Record production of 4.7 million oil-equivalent barrels a day, the highest in over forty years. Guyana at 715 thousand barrels a day with eight vessels planned by 2030. Two-thirds of production from the three lowest-cost positions. 13.7 percent debt to capital. We are not making a bearish case about Exxon the company. We are making a neutral case about Exxon the share price, and the distinction is the entire dive.
• Positive surprise that would force a re-rate upward: a Q3 print at or above the $3.53 consensus with a negative or neutral timing-effects line — that would demonstrate the run-rate is operational rather than accounting. Also: an acceleration in the buyback above the $10 billion first-half pace, or a Guyana milestone pulling Uaru or Whiptail forward. Watchable: quarterly buyback dollars and average price against the $149.93 first-half average.
• Negative surprise that would break the thesis: a resolution of the Middle East disruption that returns volumes but collapses realisations — the filing's bridge says Exxon would give up roughly $9 billion of price and margin benefit to recover roughly $1.5 billion of volume. Also: any slowdown in the buyback, which at 96 percent free-cash-flow coverage is the first thing that gives. Watchable: cash flow from operations against the $27-29 billion capex guide.

Synthos fair values

All three anchors are multiples of the FY2027 consensus earnings per share of $10.553 (14 analysts, the deepest coverage in the file), cross-checked against book value and free cash flow.

• Bear ~$118 — 11.2x FY27E. Cross-check: 1.90x book, and roughly a 6.2 percent free-cash-flow yield on the FY2025 figure. The scenario: the Middle East disruption resolves, realisations and refining margins normalise, earnings per share settle nearer $9, and the multiple gives back most of the twelve-month expansion toward its own recent 14x. Still 11 percent above the 52-week low of $105.83. −23.4 percent.
• Base ~$157 — 14.9x FY27E, essentially today's multiple. Cross-check: 2.53x book, and a total return of roughly 8 percent including the 5.8 percent shareholder yield. The scenario: the business does what consensus says, earnings plateau, the crowd's new multiple sticks, and the return is the payout. +2.0 percent.
• Bull ~$196 — 18.6x FY27E. Cross-check: 3.15x book. The scenario: the disruption-era price environment proves structural rather than cyclical, Guyana and Golden Pass add volume into a tight market, earnings per share reach the FY2030 consensus of $12.40 sooner than 2030, and the market pays a high-teens multiple for a low-beta cash machine. +27.3 percent.

Base is 2.0 percent above spot; asymmetry roughly 1.2:1 to the upside (23 percent down, 27 percent up) but with the base case sitting essentially at spot. A base case within two percent of the price, in a name where the street's low target is also the price, is the textbook definition of a Hold.

7. Knowledge base — 29 claims, 14 sources, and one consequential recantation

Tracked knowledge-base claims naming Exxon: 29. Raw hits: 29. Discarded: 0. Quarantined (quarantine_misattributed): 0.

The search covered XOM, Exxon, ExxonMobil and Exxon Mobil as entity matches across all 51,928 knowledge-base records. Every hit was a genuine reference — no name collisions. Fourteen distinct sources, spanning 2017-06-01 to 2026-06-22. Stance distribution: 23 bullish, 3 bearish, 3 neutral.

There are ZERO ExxonMobil management voices in this lane — no XOM_mgmt, no chief-executive claims. That is unusual and it is a genuine strength: nothing here needs half-weighting for management framing. One claim (2026-02-27) carries the andy_jassy_mgmt slug, but it is a different company's executive commenting on a market rotation into Walmart, Johnson & Johnson, Exxon and Verizon — not competence on this name, and weighted near zero accordingly.

The recantation — the most important claim in the lane:

> 2026-06-21 · bearish · conviction 45 · entities: oil, XOM, CVX

> "The oil mega-spike thesis is refuted — Brent futures and dated Brent back in line after the 140 spike; gas below $4, no spike to 300 coming. Admits his long Exxon/Chevron has only cost money."

This is the most recent claim in the lane and it comes from its most prolific and most convicted contributor — the same voice responsible for:

> 2025-07-20 · bullish · conviction 92 · entities: XOM, CVX, FCX, CAT, DE, PH

> "Pounding the table on these megacap energy/industrial 'power' names — they've underperformed and trade very cheap two years out versus Mag 7/software, and are needed for the AI power buildout."

> 2026-06-22 · bullish · conviction 75 · entities: CVX, XOM

> "Chevron and Exxon will be rerated as 'the electron giants for the AI age' — insatiable AI energy demand makes them AI plays, not just oil companies."

When the highest-conviction bull in a lane marks his own position to market and says it "has only cost money," that is worth more than several new bullish claims. It is also, notably, the correct observation about a stock that has been flat for three months while the market rose 7.6 percent. It is the reason the conviction rating here is Moderate and not Moderate-High.

The company-specific bull case — claims about EXXON rather than about OIL:

> 2026-05-27 · doomberg · bullish · conviction 58 · entity: XOM

> "Exxon is a remarkable execution story (Guyana); if picking one energy name to catch a dividend on, it would be Exxon."

> 2026-06-22 · bankless · bullish · conviction 68 · entity: XOM

> "Great buying opportunity in ExxonMobil, oil-services funds, natural gas companies, and US-orbit Latin America energy plays at cheap prices ahead of his higher-oil restocking thesis."

> 2024-08-14 · real_vision · bullish · conviction 80 · entities: Franco Nevada, Exxon Mobil, Agnico Eagle

> "Long-duration disciplined capital allocation (Franco's recycle ratio and 11bp culture, Exxon and Agnico Eagle's decades of outperformance) is the durable edge."

> 2026-03-18 · odd_lots · bullish · conviction 60 · fact · entities: ExxonMobil, Golden Pass, Qatar

> "Golden Pass (30% ExxonMobil / 70% Qatar), a flipped import terminal, is loading now and may be Qatar's only LNG revenue source while Gulf supply is disrupted."

> 2026-01-03 · geopolitical_cousins · bullish · conviction 55 · entities: ExxonMobil, XOM, Guyana

> "US majors can restart Venezuelan oil infrastructure; Guyana also benefits from the regional shift, though extraction is hard."

The distinction that matters, and it cuts against the raw count. Of the 23 bullish claims, we count roughly six that are genuinely about Exxon the company — the execution, the capital allocation, the Guyana position, Golden Pass. The remaining seventeen are bullish on OIL, on ENERGY as a sector, or on a macro regime (higher oil after a Hormuz closure; energy as the late-cycle baton; the AI power buildout; the Iran conflict; energy up 28 percent year to date). Those are perfectly good claims and several are high-conviction, but they are not company conviction and should not be counted as such. A lane of six company-specific bullish claims across four sources over two years is Moderate, not High — and it is why the conviction rating in the front matter says so.

The bear and caution lane, which is small but methodologically sharp:

> 2024-01-04 · we_study_billionaires · neutral · conviction 70 · principle

> "A low PE on a capital-intensive commodity business like Exxon is misleading — maintenance capex means it's not as cheap as the multiple suggests."

> 2026-02-13 · money_of_mine · bearish · conviction 45 · entity: XOM

> "Oil super-majors are really expensive, at/near all-time highs on passive flows while chemicals/refining earnings fall; optimist says they price higher oil, pessimist says massively overvalued."

> 2017-06-01 · invest_like_the_best · bearish · conviction 75 · principle · entity: Exxon Mobil

> "High capex/asset-base growth tends to predict poor future returns because cash-flush managers spend undisciplined; success requires high, retroactively-enforced hurdle rates."

The 2017 claim is a principle rather than a call, and it is uncomfortably live: capital expenditure has risen from $18.4 billion (FY2022) to $28.4 billion (FY2025), guided to $27-29 billion for 2026, while free cash flow fell 60 percent over the same period. That is exactly the pattern the claim warns about. It is a reason to watch the capital programme rather than a reason to sell, but it belongs in the kill criteria and it is there.

Lane freshness. The most recent claim is 2026-06-22, six weeks before this dive — and it sits one day after the recantation, from a different voice, arguing the opposite. The lane has not been updated through the second-quarter print. A conviction lane that has not seen the numbers this dive is built on is weaker evidence than its count suggests, and it is reported that way.

8. Data integrity — what we rejected from the vendor file and why

Seven material issues. Listed rather than silently corrected.

1. seg_geo FY2025 is CORRUPT and is REJECTED. The FY2025 geographic split reports Non-US $385.546 billion and United States $276.862 billion — a total of $662.408 billion against reported FY2025 revenue of $323.905 billion. The split is 2.05 times consolidated revenue. FY2024 (Non-US $200.590B + US $138.657B = $339.247B) and FY2023 ($207.323B + $127.374B = $334.697B) tie exactly to reported revenue, so this is a FY2025-specific defect — almost certainly gross, pre-elimination segment revenue presented as if consolidated. The FY2025 geographic split is not used anywhere in this dive. FY2024 and earlier are usable and show roughly 59 percent non-US.

2. seg_prod FY2023 and FY2024 are MISSING, and the FY2025 labels changed basis. The product/segment series jumps from FY2025 straight back to FY2022. The FY2025 entry uses the company's four current reportable segments plus two income-statement lines — Upstream $55.662B, Energy Products $217.757B, Chemical Products $18.885B, Specialty Products $17.272B, Other Revenue $2.054B, Income From Equity Affiliates $5.330B, totalling $316.960 billion against reported revenue of $323.905 billion, a $6.945 billion gap. The FY2022 and earlier entries use a US/non-US split of the old segment structure (including a "Downstream" segment that no longer exists) and are not comparable. The 10-Q's Note 3 confirms the current structure — "Our four reportable segments are Upstream, Energy Products, Chemical Products, and Specialty Products" — so the FY2025 labels are right even though the total does not tie. Stated as a gap; no segment percentage in this dive is drawn from the unreconciled residual.

3. The vendor's quarterly revenue disagrees with earn_cal by roughly $2 billion every quarter — FILING-CONSISTENT FIGURES PREFERRED, DIFFERENCE FLAGGED. inc_q reports Q2'26 revenue of $114.529 billion while earn_cal.revenueActual reports $116.017 billion; Q1'26 is $83.161B versus $85.138B; Q4'25 is $80.039B versus $82.308B. The gap is consistently $1.5-2.3 billion and is almost certainly the difference between "Sales and other operating revenue" and "Total revenues and other income" (which adds income from equity affiliates and other income). The 10-Q's financial-statement tables were lost in text extraction and cannot adjudicate directly, but the FY2025 seg_prod entry shows "Income From Equity Affiliates" at $5.330 billion — roughly $1.3 billion a quarter — which supports that explanation. This dive uses the inc_q series consistently for revenue and does not mix the two.

4. est EBITDA, EBIT and net-income rows are REJECTED; only epsAvg is used. Per the data contract these rows are corrupt in roughly 70 percent of files, and this one fails the test. est.netIncomeAvg divided by est.epsAvg implies share counts of 4,468M (FY2026E), 4,362M (FY2027E) and 4,507M (FY2028E) — non-monotonic, and rising at a company that repurchased 66.7 million shares in six months and has taken the count from 4,305M to roughly 4,144M. Separately, est.ebitdaAvg for FY2025 is $72.595 billion, against a FY2025 operating income of $33.938 billion plus first-half-2026-implied depreciation running near $31 billion annualised — the estimate row is materially above any reasonable reconstruction. All forward valuation in this dive runs on epsAvg, which the contract identifies as the reliable series and which ties coherently to the actual quarterly path.

5. tech and quote disagree on the 52-week high, and on both moving averages — tech used, disagreement stated. quote.yearHigh reports $176.41 while tech.hi52 reports $171.47, a $4.94 (2.9 percent) difference that changes the drawdown from −12.7 percent to −10.2 percent. The lows are close ($105.53 versus $105.83). Moving averages differ slightly too: 50-day $146.395 (quote) versus $146.344 (tech); 200-day $139.155 versus $139.581. We use the tech block throughout because it is internally consistent with the pct_from_hi and pct_from_lo fields computed from the same close series, and we state the alternative.

6. tech.ret_3m is reported as 0.1757 while every peer field on the same object (spy_3m 7.593, qqq_3m 7.670, spy_12m 24.257) is in whole percent — READ AS +0.18 PERCENT and flagged as unit-ambiguous. Read that way the series is coherent: +0.18 percent over three months, +11.24 percent over six, +40.42 percent over twelve — a stock that ran hard nine to twelve months ago and has been flat since. Read as a fraction it would be +17.6 percent over three months, which is irreconcilable with a +11.2 percent six-month figure. We take the percent reading, and no conclusion in this dive is sensitive to it.

7. The peer market capitalisation for BP is CORRUPT and REJECTED. peers reports BP p.l.c. at a share price of $42.44 and a market capitalisation of $18,549,852,032. Those two numbers are irreconcilable for BP by roughly an order of magnitude. No BP comparison is drawn. The other peer capitalisations (Chevron $379.2B, Shell $250.5B, TotalEnergies $189.7B, Petrobras $120.6B, Equinor $93.6B, Suncor $76.2B, Imperial Oil $62.4B) are plausible and are used only for scale.

8. The vendor profile.description is STALE. It states reserve and well counts "As of December 31, 2021" — more than four years out of date — and describes the company in the old three-division structure ("Upstream, Downstream, and Chemical") that the 10-Q's Note 3 supersedes with four reportable segments. Only the identity fields (name, CIK, sector, industry, chief executive Darren W. Woods, 58,000 employees, headquarters in Spring, Texas) are used from the profile. All operating description in this dive comes from the filings.

Not defects, correctly reported — and worth saying so. km_ttm.enterpriseValueTTM of $669.903 billion implies net debt of $31.780 billion and matches the 10-Q's $31.8 billion; the usual short-term-investments omission does not arise because this issuer genuinely holds none. cashPerShareTTM of $2.537 reconciles to the filing's $10.6 billion of cash. bookValuePerShareTTM of $63.757 includes noncontrolling interests while shareholdersEquityPerShareTTM of $62.144 excludes them — we use $62.144 and a price-to-book of 2.48x. researchAndDevelopementToRevenueTTM and stockBasedCompensationToRevenueTTM of 0 reflect fields the vendor does not populate for this issuer rather than an economic zero, and neither is used.

9. Technicals — extended, and stalled

• Price $153.97, down 0.70 percent today — the only decliner in this batch on a day when semiconductors rallied hard across the board. Intraday low $149.09, high $154.84, previous close $155.06. Volume 11.19 million against a 16.69 million average — 67 percent of normal, which argues rotation rather than distribution.
• ABOVE both moving averages, meaningfully: +5.2 percent over the 50-day of $146.34 and +10.3 percent over the 200-day of $139.58. Both are rising. This is the opposite technical configuration to a value entry.
• RSI 70.3 — overbought. MACD +3.30 — positive and extended.
• −10.2 percent from the 52-week high of $171.47; +45.5 percent above the 52-week low of $105.83. The stock sits in the upper portion of its annual range.
• Relative performance: 12-month +40.4 percent versus SPY +24.3 percent and QQQ +30.8 percent — a 16-point outperformance against the index and 10 points against the growth index, which for an energy major is a large win. 6-month +11.2 percent versus SPY +11.1 percent — dead in line. 3-month +0.18 percent versus SPY +7.6 percent and QQQ +7.7 percent — a 7.4-point deficit.
• The shape of that sequence is the whole technical story: all of the outperformance happened between nine and twelve months ago, and the name has done nothing for a quarter. That is consistent with a commodity re-rating that has run its course, and consistent with the knowledge base's own bull marking his position to market on 2026-06-21.
• Sentiment corroboration: 22 buy, 28 hold, 5 sell. Spot of $153.97 sits essentially at the street's LOW target of $153, against a consensus of $171.58 and a high of $184.
• Practical read: this is not an entry setup. RSI 70, ten percent above the 200-day, at the top of the range, three months of underperformance, no catalyst for 87 days, and a base fair value two percent above spot. There is no technical argument for buying here and no urgent one for selling. That is a Hold.

10. Insiders — nothing to read, and we say so rather than inventing a signal

The insider block contains eight transactions, and not one of them is an open-market purchase or sale. Every entry shows securitiesTransacted: 0 and price: 0.

These are almost certainly re-registration filings triggered by the redomiciliation. Every transaction date is 2026-07-01 — the exact effective date of the Redomiciliation Merger — and the filings are a mix of Form 3 (initial statement of beneficial ownership, which is what a new registrant's insiders must file) and Form 4 with zero shares transacted. They carry no information about anyone's view of the stock.

Corroborating this reading, the 10-Q's Item 5 states that during the three months ended 30 June 2026, "none of the Corporation's directors or officers adopted or terminated a 'Rule 10b5-1 trading arrangement' or 'non-Rule 10b5-1 trading arrangement.'" And Item 2 confirms no unregistered equity was issued or sold in the quarter.

Conclusion: there is no insider signal in this file, positive or negative. It is stated as an absence rather than dressed up as neutrality.

What there IS, and it is more informative than any insider trade: the company itself bought 66.7 million shares for $10.0 billion in the first half of 2026, at an average of $149.93. Today's price of $153.97 is 2.7 percent above the level at which the best-informed buyer in the market has been accumulating. That is a mildly cautionary datapoint, not a bullish one.

11. Verdict, kill-criteria and flip conditions

Hold.

The business is excellent and the price is fair. Those two facts together are a Hold, and it is worth being precise about why neither a Buy nor an Avoid fits.

Why not a Buy. Base fair value of $157 against a spot of $153.97 is a 2.0 percent gap — inside any reasonable error bar. The twelve-month +40 percent return contains zero earnings growth: trailing diluted earnings per share went $7.84 to $7.85 while the multiple went roughly 14x to 19.6x. The quarter that justifies the current consensus contains $2,560 million of timing effects the filing says will unwind, roughly $2,475 million of identified items, and an effective tax rate 10 points below the prior year on jurisdictional mix. Consensus models an earnings plateau, so essentially all return above the 5.8 percent shareholder yield must come from further multiple expansion. Shareholder returns are running at 96 percent of first-half free cash flow in the best quarter in years, and at 159 percent of FY2025 free cash flow. RSI is 70.3, the stock is 10.3 percent above its 200-day, and spot already sits at the street's lowest published target. The knowledge base's most convicted bull recanted six weeks ago.

Why not an Avoid. Because there is nothing wrong with the business, and a great deal right with it. Record production of 4.7 million oil-equivalent barrels a day, the highest in over forty years. 19.3 billion oil-equivalent barrels of proved reserves, 64 percent proved developed. Guyana at a record 715 thousand barrels a day, with Uaru and Whiptail on schedule, Hammerhead funded, and eight production vessels anticipated by year-end 2030. Two-thirds of production from the three lowest cost-of-supply positions, and rising. 13.7 percent debt to total capital, 59.6x interest coverage, $7.7 billion of undrawn lines. $16.3 billion of cumulative structural cost savings against 2019, still compounding at $1.2 billion a half. A 2.65 percent dividend plus a 3.1 percent buyback. And a beta of 0.162, which makes this one of the few genuinely uncorrelated large-cap holdings available.

What you are accepting by holding. Peak-cycle earnings in the denominator of a 19.6x multiple. A price environment created by a supply disruption that could resolve. A capital programme rising into falling free cash flow. And no catalyst for 87 days.

Pre-registered KILL criteria — what would move this to Avoid:

• A Q3'26 print that misses the $3.53 consensus AND shows a large negative Estimated Timing Effects line in Energy Products — that combination would confirm the second quarter was partly an accounting artifact and that the FY2026 consensus of $11.07 is unreachable.
• The buyback slowing materially below the $10 billion half-year pace while the dividend holds. At 96 percent free-cash-flow coverage the buyback is the shock absorber, and cutting it is the earliest available signal that the cash cycle has turned.
• Free cash flow falling below the dividend on a trailing-twelve-month basis — the dividend was $17.231 billion in FY2025 against $23.612 billion of free cash flow, so the cushion is roughly $6.4 billion and shrinking.
• Capital spending guidance rising above the $27-29 billion range without a corresponding volume commitment. This is the knowledge base's oldest and sharpest bearish principle: "High capex/asset-base growth tends to predict poor future returns."
• A material disruption to the Kazakhstan export route. The 10-K sizes it: roughly $1.1 billion of 2025 after-tax earnings and 320 thousand oil-equivalent barrels a day, exported through a pipeline traversing Russia, with the filing explicitly warning it "could be disrupted, curtailed, temporarily suspended, or otherwise restricted."
• A decisive break below the 200-day moving average of $139.58 on company-specific news rather than commodity beta.

Pre-registered FLIP TO BUY (upgrade):

• A price below roughly $135 — approximately 12.8x FY2027 consensus and near the 200-day — at which the base case offers a 16 percent gap rather than a 2 percent one, and the shareholder yield alone approaches 6.6 percent.
• A Q3 print at or above consensus with a NEUTRAL or NEGATIVE timing-effects line, demonstrating the earnings run-rate is operational. That single disclosure would do more for this thesis than any price move.
• Trailing twelve-month earnings per share sustained above $10 — which would make the current multiple 15x rather than 19.6x and retrospectively justify the re-rating.
• An acceleration of the buyback above the $10 billion half-year pace at prices below $150, signalling management shares the view that the stock is cheap.
• A Guyana milestone pulling Uaru or Whiptail forward, or Golden Pass Train 1 reaching commercial operation ahead of plan.

Where XOM fits in the Synthos Framework Portfolio. The low-beta / real-asset diversifier sleeve, as an existing 1-2 percent position to be maintained but not added to. The case for holding it at all is not the return forecast — it is the 0.162 beta and the fact that this equity's driver is a commodity price rather than the equity market, which is genuine diversification in a portfolio otherwise weighted toward technology and AI infrastructure. The case against adding is everything in Section 6. If new energy capital is being deployed, it should wait for the Q3 print on 2026-10-30, which will settle the timing-effects question directly. Logged as a tracked Synthos call (Hold) as of 2026-08-04 at $153.97.

Single biggest risk: that the second quarter was the peak. Q2'26 earnings of $14.5 billion — double the prior year — were driven roughly seven-to-one by price and margin over volume, included $2,560 million of favourable timing effects the filing says will unwind, and benefited from an effective tax rate 10 percentage points below the prior year. Consensus has extrapolated that run-rate through FY2028. If it proves cyclical rather than structural, the 19.6x trailing multiple is being paid on peak earnings, and the de-rating and the earnings decline would arrive together.

Most fragile assumption in the price: that the Middle East supply disruption resolves in a way that gives Exxon its volumes back without taking its prices away. The filing's own segment bridge shows the two sides explicitly — roughly $9.08 billion of price and margin benefit against roughly $1.48 billion of lost volume earnings in a single quarter. There is no plausible resolution path in which the favourable side persists and the unfavourable side reverses, and the consensus earnings path appears to assume exactly that.

Provenance & disclosures

• Traceability: 29 tagged knowledge-base claims name Exxon (breadth 14, net conviction positive-moderate), spanning 2017-06-01 to 2026-06-22 — 23 bullish, 3 bearish, 3 neutral. Searches covered XOM, Exxon, ExxonMobil and Exxon Mobil as entity matches across 51,928 records; 29 raw hits, 0 discarded, 0 quarantined, no name collisions. Zero ExxonMobil management voices appear in this lane, so no half-weighting for management framing was required; one claim carrying an andy_jassy_mgmt slug is a different company's executive commenting on a market rotation and is weighted near zero. Of the 23 bullish claims, roughly six are company-specific (execution, capital allocation, Guyana, Golden Pass) and roughly seventeen are bullish on oil, energy as a sector, or a macro regime — that distinction is drawn explicitly in Section 7 and is the reason conviction is rated Moderate rather than High. The single most consequential claim is a recantation (2026-06-21, conviction 45) from the lane's most prolific and previously most convicted bull. All quotes are verbatim from the stored claim text.
• Data as-of: fundamentals — income statement and cash flow to 2026-06-30 (Q2'26, 10-Q filed 2026-08-03, one day before this dive); annual balance sheet 2025-12-31 (FY2025) supplemented by the 10-Q's stated debt, cash and equity figures at 2026-06-30 · estimates 2026-08-04 · prices 2026-08-04 (close $153.97; 50-DMA $146.34; 200-DMA $139.58; RSI 70.3) · knowledge-base claims 2026-08-04. All figures come from the Synthos vendor data file for XOM and the SEC filings in this file; no figure comes from memory, recall or external retrieval.
• Entity attribution — the most important provenance note in this dive: the 10-K dated 2026-02-18 is the PREDECESSOR entity's, filed by EXXON MOBIL CORP (CIK 34088), and the manifest records it as predecessor: true. It is attributed as such throughout and is used for FY2025 operating, reserve and production detail. The 10-Q dated 2026-08-03 is a joint filing by Exxon Mobil Corporation and ExxonMobil Holdings Corporation, the latter as successor registrant, and covers a quarter that ended before the 1 July 2026 effective date. Both 8-Ks are the successor's (CIK 2115436). The redomiciliation was a New Jersey to Texas reorganization with a one-for-one share exchange; the filing states it "did not change the Corporation's consolidated business, operations, assets, liabilities, or financial reporting basis." The only substantive change is that shareholder rights now fall under the Texas Business Organizations Code.
• Filing-versus-vendor resolutions: (a) the vendor's enterprise value of $669.903 billion is CORRECT — it implies net debt of $31.780 billion against the 10-Q's stated $31.8 billion, and this issuer genuinely holds no short-term investments, so the usual omission does not arise; this is recorded because honesty runs both ways. (b) The vendor's FY2023 and FY2024 totalDebt includes capital lease obligations while FY2025 does not; the filing defines total debt as notes and loans payable plus long-term debt and reports $43.5 billion at year-end 2025, matching the vendor's FY2025 figure, so FY2025 is used and the earlier years are treated as non-comparable. (c) The vendor's Q2'26 net income of $14.525 billion reconciles exactly to the filing's stated $14.5 billion quarter and $18.7 billion half. (d) The vendor's adjusted earnings per share of $3.52 could NOT be reconciled to the filing's $2,475 million of identified items; the reconciliation is left open rather than forced, and this dive uses GAAP figures and the filing's own driver bridge.
• Data rejections (detailed in Section 8): seg_geo FY2025 rejected as corrupt (a US-plus-non-US split totalling $662.408 billion against $323.905 billion of reported revenue — 2.05x); seg_prod FY2023 and FY2024 missing and pre-2023 labels non-comparable, with the FY2025 entry short of reported revenue by $6.945 billion; all est EBITDA, EBIT and net-income rows rejected (implied share counts of 4,468M/4,362M/4,507M are non-monotonic and rising at a company retiring shares), with epsAvg used exclusively for forward valuation per the data contract; quote.yearHigh ($176.41) rejected in favour of tech.hi52 ($171.47) for internal consistency, with both stated; tech.ret_3m read as +0.18 percent and flagged as unit-ambiguous; the peer market capitalisation for BP ($18.55 billion against a $42.44 share price) rejected as corrupt, with no BP comparison drawn; profile.description rejected as stale (cites reserve data "As of December 31, 2021" and the superseded three-division structure).
• Known gaps, stated rather than papered over: both 8-K extracts contain only the cover page — the Item narrative and all exhibits, including the Q2'26 earnings release, were lost in extraction. The 10-Q's financial-statement tables were also lost in text extraction, so the income statement, balance sheet and cash-flow statement could not be read line by line; all filing figures used here come from the narrative MD&A, the notes, and the liquidity discussion, each quoted or cited specifically. Earnings-call transcripts are not available on this data plan, so no management Q&A informs this dive. No Item 1A. Risk Factors update appears in the Q2 10-Q, so no risk factor is reported as having changed since the FY2025 annual report.
• Estimate coverage: FY2026E 8 analysts on earnings per share and 8 on revenue; FY2027E 14 on earnings per share and 10 on revenue — the deepest coverage in the file and the primary forward anchor; FY2028E 7 and 10. FY2029E (2 analysts on earnings per share) and FY2030E (5) are too thin to anchor anything and no conclusion rests on them; the FY2030 figure of $12.40 is cited once, in the bull scenario, explicitly labelled.
• Peer note: Chevron ($379.2B), Shell ($250.5B), TotalEnergies ($189.7B), Petrobras ($120.6B and $106.5B across two classes), Equinor ($93.6B), Suncor ($76.2B), Imperial Oil ($62.4B — in which the 10-K discloses Exxon holds a 69.6 percent interest, so it is not an independent comparable), Cenovus, Ecopetrol and YPF are the vendor peer set. BP's entry is corrupt and excluded. No peer multiples are supplied in the file, so no peer-multiple comparison is drawn.
• Fair-value caveat: the $118 / $157 / $196 anchors are multiples of the FY2027 consensus earnings per share of $10.553 (11.2x / 14.9x / 18.6x), cross-checked against book value per share of $62.144 and the free-cash-flow yield. Stated arithmetic, not a discounted cash flow. The base case assumes the multiple holds, not that it expands; the bear case is a return toward the ~14x trailing multiple of twelve months ago; the bull case requires disruption-era earnings to prove structural and is flagged as the fragile leg.
• Basis note: all earnings figures in this dive are GAAP unless explicitly labelled. Q2'26 GAAP diluted earnings per share were $3.48 and the vendor's adjusted "actual" was $3.52; those two cannot be reconciled to the filing's $2,475 million of identified items, and the vendor's adjusted series is therefore treated as unverified and used only where labelled.
• Timing: the Q2'26 earnings release was 2026-07-31, four days before this dive, and the 10-Q was filed 2026-08-03, one day before — so the most recent quarter is fully reflected. The next print is 2026-10-30, 87 days away. There is no near-term catalyst, and that is an explicit part of the Hold rather than an oversight.
• Not investment advice. Independent research, educational and informational only, never personalised. No recommendation to buy, sell or hold any security is made to any person.
• Version: 2026-08-04-full.